Deputy Minister of Health and Social Protection Samariddin Alizoda said the Ministry would conduct after-vaccination health checkers for people who received the vaccine.
The Ministry of Health and Social Protection of Tajikistan does not intend to refuse the AstraZeneca drug as a coronavirus vaccine. Deputy Minister of Health and Social Protection Samariddin Alizoda made this statement during a press conference on March 18, the press office of the Ministry of Health and Social Protection reported.
This week several European countries have suspended the use of the AstraZeneca vaccine due to the number of cases of blood clots reported in vaccinated people.
Alizoda said Tajikistan was using the AstraZeneca drug code-named Covishield, produced not in Europe, but in India, noting that the Serum Institute of India known as the world’s largest professional community was behind the Covishield vaccine.
He emphasised that the Ministry of Health and Social Protection would conduct after-vaccination health checkers for people who received the vaccine and report side effects following vaccination.
The Deputy Minister said Tajikistan was currently working to register the vaccines Sputnik from the Russian Federation and CoronaVac from China. He emphasised that every citizen of the country would take whichever vaccine was offered.
